Pancreatic Tumors
Showing 1 - 25 of >10,000
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
Pancreatic Cancer Trial in Baltimore (VectRx Thermal Therapy)
Recruiting
- Pancreatic Cancer
- VectRx Thermal Therapy
-
Baltimore, MarylandUniversity of Maryland
Jul 26, 2023
Advanced Pancreatic Carcinoma, Locally Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Trial in Rochester
Recruiting
- Advanced Pancreatic Carcinoma
- +9 more
- Endoscopic Ultrasound
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 13, 2022
Modified Frailty Index for Minimally Invasive Distal
Completed
- Postoperative Complication
- Modified frailty index
-
Seoul, Republic Of Korea, Korea, Republic ofAsan medical center
Apr 19, 2023
Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Completed
- Zollinger Ellison Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
Pancreatic Tumor Trial in Columbus (Chemical Ablation, Computed Tomography, Electronic Health Record Review)
Recruiting
- Pancreatic Neoplasm
- Chemical Ablation
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 18, 2023
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Multi-dimensional Fragmentomic Assay for Early Detection of
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Fragmentomic profiles of plasma cfDNA
- (no location specified)
Apr 27, 2023
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic
Recruiting
- Pancreatic Neoplasms
- +2 more
- cfDNA methylation sequencing and proteome analysis
-
Shanghai, Shanghai, ChinaChanghai Hospital
Feb 17, 2023
Non-functional Neuroendocrine Tumors of Pancreatic Body and Tail
Recruiting
- Non Functioning Pancreatic Endocrine Tumor
- Histopathological review, long-term prognosis and quality of life follow-up
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Jun 8, 2023
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (68Ga-DOTATOC)
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- (no location specified)
Oct 16, 2023
Benign Pancreatic Tumor, Chronic Pancreatitis, Recurrent Acute Pancreatitis Trial in Portland (Pancreatectomy, Quality-of-Life
Not yet recruiting
- Benign Pancreatic Neoplasm
- +2 more
- Pancreatectomy
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 7, 2022
Pancreatic Cancer Resectable Trial (Acetylsalicylic acid, Placebo)
Not yet recruiting
- Pancreatic Cancer Resectable
- Acetylsalicylic acid
- Placebo
- (no location specified)
Dec 5, 2022
Through Detection of Elastase-1 Combined With Other Examinations
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +5 more
- Pancreatic elastase-1 in blood serum
-
Jinan, Shandong, ChinaNing Zhong
Sep 10, 2023
Development of New Personalised 3D Preclinical Models of
Recruiting
- Pancreatic Neuroendocrine Tumor
-
Milan, MI, ItalyIRCCS San Raffele Institute
Nov 2, 2023
Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,
Not yet recruiting
- Advanced Gastroenteropancreatic Neuroendocrine Tumor
- Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
- long-acting Octreotide.
- (no location specified)
May 22, 2023
Nonfunctional Pancreatic Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor, Endoscopic Ultrasound Trial in Nanning
Recruiting
- Nonfunctional Pancreatic Neuroendocrine Tumor
- +2 more
- EUS-guided ethanol ablation
- EUS-guided lauromacrogol ablation
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 30, 2022
Pancreatic Tumor, Benign, Pancreatic Neuroendocrine Tumor, Solid Pseudopapillary Tumor of the Pancreas Trial in Shanghai (MPD
Not yet recruiting
- Pancreatic Tumor, Benign
- +2 more
- MPD Repair or Reconstruction
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Aug 29, 2023
Pancreatic and Periampullary Tumors in Greenland Inuit
Completed
- Pancreatic Neoplasms
- Periampullary Neoplasms
- outcome
- (no location specified)
Oct 26, 2022
Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Pancreas Cancer
- cytoreductive surgery
- +2 more
-
Chicago, IllinoisThe University of Chicago
Nov 8, 2022
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Multiple Endocrine Neoplasia Type 1, Pancreatic Neuroendocrine Tumor Trial in Nanning (EUS-guided fine-needle injection)
Recruiting
- Multiple Endocrine Neoplasia Type 1
- Pancreatic Neuroendocrine Tumor
- EUS-guided fine-needle injection
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Sep 24, 2022
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Recruiting
- Tumor, Solid
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 30, 2022